These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4956154)

  • 41. [Effect of inderal on the coronary blood circulation].
    Kaverina NV; Kareva GF; Markova GA
    Farmakol Toksikol; 1968; 31(2):169-74. PubMed ID: 5674669
    [No Abstract]   [Full Text] [Related]  

  • 42. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
    Stormorken H
    Tidsskr Nor Laegeforen; 1971 Feb; 91(6):449-50. PubMed ID: 5546533
    [No Abstract]   [Full Text] [Related]  

  • 43. [Current problems in the medical treatment of coronary insufficiency].
    Cunescu V; Pîrvu V
    Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography.
    DAHL M; KASANEN A; PELTONEN T
    Ann Med Exp Biol Fenn; 1962; 40():423-6. PubMed ID: 14024623
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of coronary vasodilators on cornary blood flow in man.
    Hilger HH
    Brux Med; 1970 Sep; 50(9):557-65. PubMed ID: 5510355
    [No Abstract]   [Full Text] [Related]  

  • 46. [Inderal (propanolol) and coronary circulation].
    Malcolm J; Waycott J
    Rev Med Liege; 1969 Apr; 24(8):352-3. PubMed ID: 5403430
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the treatment of coronary circulatory disorders. With special reference to the pyrimidopyrimidine derivative Persantin].
    Friedemann M
    Schweiz Med Wochenschr; 1966 Dec; 96(49):1656-60. PubMed ID: 5340049
    [No Abstract]   [Full Text] [Related]  

  • 48. [Internal medical diagnosis and therapy of coronary insufficiency].
    Tschirdewahn B
    Med Klin; 1969 Apr; 64(16):729-32. PubMed ID: 4977313
    [No Abstract]   [Full Text] [Related]  

  • 49. [Current aspects of chemotherapy of ischemic heart disease].
    Kaverina NV
    Kardiologiia; 1973 Dec; 13(12):5-13. PubMed ID: 4149803
    [No Abstract]   [Full Text] [Related]  

  • 50. Difference in site and time course of coronary dilating effects of trapidil, nitroglycerin and dipyridamole in anesthetized dogs.
    Noguchi K; Tomoike H; Ootsubo H; Sakai K; Nakamura M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):809-14. PubMed ID: 6795344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Distribution of dipyridamole, a selective coronary dilating substance, between plasma, cellular and aqueous phase in man and dogs. A contribution on the dosage of the drug in man].
    Kübler W; Bretschneider HJ; Spieckermann PG
    Arzneimittelforschung; 1969 Feb; 19(2):185-90. PubMed ID: 5818756
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dipyramidole in the therapy of acute coronary syndromes].
    Novelli E; Cecchi A
    Minerva Cardioangiol; 1972 Apr; 20(4):179-216. PubMed ID: 5023725
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in diameters of small pulmonary venous and arterial vessels after nitroglycerin (author's transl)].
    Kober G; Grossmann R; Schulz W; Kaltenbach M
    Z Kardiol; 1981 Jul; 70(7):547-54. PubMed ID: 6791396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ["Extracoronary" effect of carbochromen on the circulation].
    Votcal BE; Zmurkin VP; Rogunov GA; Trosina TP; Alijeva ZM
    Arzneimittelforschung; 1970 Mar; 20():442-6. PubMed ID: 5468727
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypoxia and the heart ultrastructure with special reference to the protective action of the coronary drug Persantin.
    Lozada BB; Laguens RP
    Cardiologia (Basel); 1966; 49():Suppl 1:33-43. PubMed ID: 5989065
    [No Abstract]   [Full Text] [Related]  

  • 57. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanisms of the therapeutic action of vasodilator agents in cardiac insufficiency (review of the literature)].
    Chekman IS; Kazak LI
    Vrach Delo; 1981 Apr; (4):10-5. PubMed ID: 6115515
    [No Abstract]   [Full Text] [Related]  

  • 59. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs.
    Hintze TH; Vatner SF
    Circ Res; 1983 Feb; 52(2 Pt 2):I139-46. PubMed ID: 6403258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.